Cancer Family
Leukemia
CI-CAN-00000215Explore in graph →
HematologicTop-level1,769 active trials42 approved drugs708 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000215Explore in graph →
Clinical trials
8,437 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,348)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06783816 | A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors | recruiting | N/A | 45 | Shanxi Bethune HospitalOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06785077 | Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors | recruiting | N/A | 157 | European Institute of OncologyOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06781515 | Assessment of Disease Burden in Hairy Cell Leukemia(BRAF) | recruiting | N/A | 45 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT05528939 | Feasibility/Acceptability of Attentional-Control Training in Survivors(FAACTS) | recruiting | N/A | 50 | Children's National Research InstituteOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06758726 | Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML | not yet recruiting | N/A | 20 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 0 | Jan 6, 2025 | clinicaltrials |
| NCT06643195 | Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia | not yet recruiting | N/A | 358 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Dec 30, 2024 | clinicaltrials |
| NCT06746571 | Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients | not yet recruiting | N/A | 100 | Sohag UniversityOTHER | 1 | Dec 24, 2024 | clinicaltrials |
| NCT03595787 | COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome(COHABILIT) | active not recruiting | N/A | 50 | Institut Paoli-CalmettesOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06722638 | Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia(VIRALL) | recruiting | N/A | 40 | Children's National Research InstituteOTHER | 1 | Dec 9, 2024 | clinicaltrials |
| NCT06702566 | The Effect of Serum Ferritin in irAE | recruiting | N/A | 1,500 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT06643962 | Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy | recruiting | N/A | 83 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06678282 | JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia | recruiting | N/A | 20 | Shenzhen Genocury Biotech Co., Ltd.INDUSTRY | 1 | Nov 7, 2024 | clinicaltrials |
| NCT05703126 | Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML | recruiting | N/A | 100 | Samara State Medical UniversityOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT06658938 | Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation | not yet recruiting | N/A | 30 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 0 | Oct 26, 2024 | clinicaltrials |
| NCT06654583 | Effectiveness of Developed Interactive Play Mat In Pediatric Physical Therapy | active not recruiting | N/A | 54 | Superior UniversityOTHER | 1 | Oct 23, 2024 | clinicaltrials |
| NCT06625372 | Comparison of Intralipid With SMOF Lipid Following HSCT | recruiting | N/A | 50 | Shahid Beheshti UniversityOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT06631196 | Jacobson's Progressive Muscle Relaxation Technique on Children With Leukemia Undergoing Chemotherapy.(JPMRT) | not yet recruiting | N/A | 80 | Alexandria UniversityOTHER | 0 | Oct 8, 2024 | clinicaltrials |
| NCT06626893 | Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention(AL-TOMICA) | recruiting | N/A | 100 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT06130787 | Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy(BIO-TIMER) | recruiting | N/A | 321 | University Hospital, Clermont-FerrandOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06591195 | Distraction As Multimodal Pain Management(DISTRACT) | not yet recruiting | N/A | 126 | Radboud University Medical CenterOTHER | 0 | Sep 19, 2024 | clinicaltrials |
| NCT06536010 | Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML | recruiting | N/A | 50 | Yang XiaotianOTHER | 1 | Aug 2, 2024 | clinicaltrials |
| NCT06301425 | MRD Response-adapted Allo-HSCT for Adverse-risk AML | recruiting | N/A | 178 | Peking University People's HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT06475469 | Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk | recruiting | N/A | 75 | CHU de ReimsOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT05950997 | A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL | recruiting | N/A | 89 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06364033 | Biological and Clinical Efficacy of Shingrix in Patients With CLL | not yet recruiting | N/A | 312 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06385808 | Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML | not yet recruiting | N/A | 37 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Apr 26, 2024 | clinicaltrials |
| NCT06090786 | Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax | not yet recruiting | N/A | 225 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 0 | Apr 10, 2024 | clinicaltrials |
| NCT06329999 | A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML | recruiting | N/A | 78 | Ruijin HospitalOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06328179 | Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA. | recruiting | N/A | 34 | Huai'an First People's HospitalOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT06256627 | The Maintenance Treatment of "ITIVA" in AML Patients | recruiting | N/A | 130 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 13, 2024 | clinicaltrials |
| NCT06237192 | MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients | recruiting | N/A | 200 | National Research Center for Hematology, RussiaNETWORK | 1 | Feb 1, 2024 | clinicaltrials |
| NCT06232694 | Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML | recruiting | N/A | 54 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT04105530 | Transcranial Direct Current Stimulation of the Temporal Cortex in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) | active not recruiting | N/A | 36 | St. Jude Children's Research HospitalOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT05839392 | Novel Approaches to Target MECOM/EVI1 in AML | recruiting | N/A | 24 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT06155188 | Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia | recruiting | N/A | 60 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Dec 4, 2023 | clinicaltrials |
| NCT06066905 | A Study of Chidamide With AZA in MRD Positive AML After Transplant | recruiting | N/A | 60 | Guangdong Provincial People's HospitalOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT05909293 | Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission | recruiting | N/A | 100 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jun 18, 2023 | clinicaltrials |
| NCT04179929 | Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults | recruiting | N/A | 300 | PETHEMA FoundationOTHER | 1 | Feb 18, 2022 | clinicaltrials |
| NCT05161026 | Impact of Allo-HSCT on Bone Remodeling: Evolution of Bone Mineral Density and Architecture Measured by Bone Densitometry(REMODALLO) | not yet recruiting | N/A | 120 | University Hospital, CaenOTHER | 1 | Dec 16, 2021 | clinicaltrials |
| NCT04209244 | Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia | recruiting | N/A | 100 | Rigshospitalet, DenmarkOTHER | 1 | Dec 26, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Jan 20, 2025source: clinicaltrials